Comprehensive Analyses of miRNAs Revealed miR-92b-3p, miR-182-5p and miR-183-5p as Potential Novel Biomarkers in Melanoma-Derived Extracellular Vesicles.

biomarker extracellular vesicles (EVs) melanoma miRNAs skin cancer (melanoma)

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2022
Historique:
received: 04 05 2022
accepted: 16 06 2022
entrez: 28 7 2022
pubmed: 29 7 2022
medline: 29 7 2022
Statut: epublish

Résumé

Extracellular vesicles (EVs) are important mediators in the intercellular communication, influencing the function and phenotype of different cell types within the tumor micro-milieu and thus promote tumor progression. Since EVs safely transport packages of proteins, lipids and also nucleic acids such as miRNAs, EVs and their cargo can serve as diagnostic and prognostic markers. Therefore, the aim of this study was to investigate EV embedded miRNAs specific for melanoma, which could serve as potential biomarkers. In contrast to previous studies, we not only analysed miRNAs from EVs, but also included the miRNA profiles from the EV-secreting cells to identify candidates as suitable biomarkers. While the characterization of EVs derived from normal melanocytes and melanoma cells showed largely comparable properties with regard to size distribution and expression of protein markers, the NGS analyses yielded marked differences for several miRNAs. While miRNA load of EVs derived from normal human epidermal melanocytes (NHEMs) and melanoma cells were very similar, they were highly different from their secreting cells. By comprehensive analyses, six miRNAs were identified to be enriched in both melanoma cells and melanoma cell-derived EVs. Of those, the accumulation of miR-92b-3p, miR-182-5p and miR-183-5p in EVs could be validated

Identifiants

pubmed: 35898875
doi: 10.3389/fonc.2022.935816
pmc: PMC9309285
doi:

Types de publication

Journal Article

Langues

eng

Pagination

935816

Informations de copyright

Copyright © 2022 Gerloff, Kewitz-Hempel, Hause, Ehrenreich, Golle, Kingreen and Sunderkötter.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Int J Mol Med. 2019 Jan;43(1):256-266
pubmed: 30365097
Nat Commun. 2013;4:2980
pubmed: 24356509
Cells. 2019 Jul 15;8(7):
pubmed: 31311206
Elife. 2016 Aug 25;5:
pubmed: 27559612
NPJ Precis Oncol. 2018 Dec 12;2:28
pubmed: 30564636
Cell Commun Signal. 2018 Aug 6;16(1):44
pubmed: 30081925
Front Immunol. 2020 Jan 27;10:3087
pubmed: 32047494
PLoS One. 2016 Apr 19;11(4):e0153046
pubmed: 27093275
Cell Rep. 2016 Oct 11;17(3):799-808
pubmed: 27732855
Exp Mol Pathol. 2018 Dec;105(3):371-379
pubmed: 30414979
Pharmacol Ther. 2018 Aug;188:1-11
pubmed: 29476772
Biomed Pharmacother. 2020 Jan;121:109553
pubmed: 31704611
Anticancer Res. 2017 Dec;37(12):6779-6789
pubmed: 29187456
Proteomics. 2015 Aug;15(15):2597-601
pubmed: 25921073
Sci Rep. 2017 Mar 24;7:44847
pubmed: 28337997
Mol Cancer. 2019 Apr 3;18(1):78
pubmed: 30943982
Sci Rep. 2021 Sep 17;11(1):18534
pubmed: 34535708
J Extracell Vesicles. 2021 Jul;10(9):e12121
pubmed: 34295456
Nucleic Acids Res. 2012 May;40(10):4288-97
pubmed: 22287627
Front Genet. 2020 Mar 17;11:237
pubmed: 32256526
BMC Res Notes. 2014 Mar 13;7:144
pubmed: 24625073
Cell Mol Immunol. 2019 Feb;16(2):112-125
pubmed: 29429995
Genome Biol. 2014;15(12):550
pubmed: 25516281
BMC Bioinformatics. 2019 Nov 4;20(1):545
pubmed: 31684860
Stem Cell Res Ther. 2019 Aug 23;10(1):263
pubmed: 31443679
Semin Cancer Biol. 2019 Dec;59:251-265
pubmed: 31386906
Oncogene. 2019 Feb;38(8):1256-1268
pubmed: 30254211
Nat Commun. 2017 Jan 09;8:14041
pubmed: 28067230
Nat Genet. 2006 Sep;38(9):1060-5
pubmed: 16878133
Oncogene. 2016 Nov 17;35(46):6038-6042
pubmed: 27132512
Cancer Manag Res. 2019 Dec 09;11:10307-10319
pubmed: 31849520
Life Sci. 2021 Nov 15;285:119937
pubmed: 34508764
Angiogenesis. 2019 Aug;22(3):397-410
pubmed: 30993566
Epigenomics. 2019 Jan;11(1):35-51
pubmed: 30211623
Cancers (Basel). 2020 Feb 17;12(2):
pubmed: 32079286
Curr Res Transl Med. 2022 Jan;70(1):103315
pubmed: 34837760
J Extracell Vesicles. 2013 Sep 12;2:
pubmed: 24223256
Braz J Med Biol Res. 2013 Oct;46(10):824-30
pubmed: 24141609
Methods Mol Biol. 2011;784:181-95
pubmed: 21898221
J Exp Clin Cancer Res. 2020 Apr 16;39(1):67
pubmed: 32299469
Bioscience. 2015 Aug 1;65(8):783-797
pubmed: 26955082
Gynecol Oncol. 2008 Jul;110(1):13-21
pubmed: 18589210
Bioengineered. 2021 Dec;12(1):2164-2174
pubmed: 34098850
J Thorac Dis. 2017 Oct;9(Suppl 13):S1373-S1382
pubmed: 29184676
Mol Med. 2021 Jul 16;27(1):78
pubmed: 34294040
Nat Cell Biol. 2007 Jun;9(6):654-9
pubmed: 17486113
Int J Cancer. 2017 Jul 15;141(2):220-230
pubmed: 28240776
J Exp Clin Cancer Res. 2018 Oct 3;37(1):242
pubmed: 30285793
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
J Clin Med. 2015 Dec 17;4(12):2012-27
pubmed: 26694476
Nat Commun. 2018 Jan 29;9(1):420
pubmed: 29379020
J Exp Med. 2019 Sep 2;216(9):2202-2220
pubmed: 31235510
Cells. 2020 Jul 02;9(7):
pubmed: 32630649
J Extracell Vesicles. 2015 May 14;4:27066
pubmed: 25979354
Neoplasia. 2021 Jan;23(1):149-157
pubmed: 33321449
Nature. 2004 Sep 16;431(7006):350-5
pubmed: 15372042
J Biol Chem. 2013 Apr 12;288(15):10849-59
pubmed: 23439645
Arch Pathol Lab Med. 2014 Jun;138(6):828-32
pubmed: 24878024
Pigment Cell Melanoma Res. 2021 Nov;34(6):1062-1073
pubmed: 34273912
Clin Lung Cancer. 2009 Jan;10(1):42-6
pubmed: 19289371
Cancer Cell Int. 2021 Sep 20;21(1):487
pubmed: 34544412
Cell Rep. 2016 May 3;15(5):978-987
pubmed: 27117408
Cell Death Dis. 2021 Mar 10;12(3):255
pubmed: 33692334
Nat Cell Biol. 2020 Feb;22(2):187-199
pubmed: 31932738
J Dermatol Sci. 2011 Mar;61(3):187-93
pubmed: 21273047
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
Int J Mol Sci. 2020 Sep 04;21(18):
pubmed: 32899898
PLoS One. 2017 Oct 5;12(10):e0185992
pubmed: 28982131
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Nat Commun. 2017 Feb 17;8:14448
pubmed: 28211508
Drug Discov Today. 2019 Oct;24(10):2058-2067
pubmed: 31228614
Hepatology. 2015 Apr;61(4):1284-94
pubmed: 25503676
Front Cell Dev Biol. 2021 May 31;9:661602
pubmed: 34136482
J Immunol. 2020 Nov 15;205(10):2916-2925
pubmed: 32989094
Cell. 2004 Jan 23;116(2):281-97
pubmed: 14744438
Cells. 2020 Jun 11;9(6):
pubmed: 32545155
J Pathol. 2016 Nov;240(3):329-340
pubmed: 27538493
Sci Rep. 2017 Nov 7;7(1):14634
pubmed: 29116117
Aging (Albany NY). 2020 May 3;12(9):8352-8371
pubmed: 32364530
Nat Commun. 2017 Nov 6;8(1):1319
pubmed: 29105655
Cell Signal. 2021 Nov;87:110113
pubmed: 34371055
J Transl Med. 2016 Feb 24;14:56
pubmed: 26912358
PLoS One. 2017 Aug 31;12(8):e0183435
pubmed: 28859135
PLoS One. 2012;7(10):e46874
pubmed: 23056502

Auteurs

Dennis Gerloff (D)

Department of Dermatology and Venereology, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.

Stefanie Kewitz-Hempel (S)

Department of Dermatology and Venereology, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.

Gerd Hause (G)

Biocenter, Martin Luther University Halle-Wittenberg, Halle, Germany.

Jovine Ehrenreich (J)

Department of Dermatology and Venereology, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.

Linda Golle (L)

Department of Dermatology and Venereology, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.

Tim Kingreen (T)

Department of Dermatology and Venereology, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.

Cord Sunderkötter (C)

Department of Dermatology and Venereology, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.

Classifications MeSH